Cassava Sciences, Inc.

SAVA

$2.78

Name : Cassava Sciences, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $134,295,952.00

EPSttm : -2.22

Cassava Sciences, Inc.

$2.78

0.72%

$0.02

Float Short %

17.69

Margin Of Safety %

Put/Call OI Ratio

0.23

EPS Next Q Diff

EPS Last/This Y

-1.4

EPS This/Next Y

0.71

Price

2.78

Target Price

Analyst Recom

Performance Q

26.94

Relative Volume

0.34

Beta

-1.04

Ticker: SAVA

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	SAVA	4.41	0.20	0.22	80477
2025-10-21	SAVA	3.98	0.20	0.34	81404
2025-10-22	SAVA	3.69	0.21	0.21	82753
2025-10-23	SAVA	3.9	0.20	0.01	83944
2025-10-24	SAVA	3.78	0.19	0.16	87615
2025-10-27	SAVA	3.81	0.20	0.11	82050
2025-10-28	SAVA	3.58	0.19	0.49	83375
2025-10-29	SAVA	3.41	0.20	0.39	84305
2025-10-30	SAVA	3.29	0.20	0.23	84879
2025-10-31	SAVA	3.24	0.20	0.16	85098
2025-11-03	SAVA	3.2	0.19	0.12	80669
2025-11-04	SAVA	2.96	0.19	0.28	81301
2025-11-05	SAVA	3.05	0.19	0.27	81069
2025-11-06	SAVA	2.96	0.19	0.10	81364
2025-11-07	SAVA	2.97	0.19	0.68	81756
2025-11-10	SAVA	3.02	0.19	0.06	79151
2025-11-11	SAVA	3.11	0.19	0.23	80000
2025-11-12	SAVA	3.27	0.19	3.82	80414
2025-11-13	SAVA	2.92	0.23	1.02	83710
2025-11-14	SAVA	2.75	0.23	1.03	83810
2025-11-17	SAVA	2.79	0.23	0.76	82805
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	SAVA	4.41	-	-	-1.93
2025-10-21	SAVA	3.97	-	-	-1.93
2025-10-22	SAVA	3.70	-	-	-1.93
2025-10-23	SAVA	3.90	-	-	-1.93
2025-10-24	SAVA	3.79	-	-	-1.93
2025-10-27	SAVA	3.81	-	-	-1.93
2025-10-28	SAVA	3.58	-	-	-1.93
2025-10-29	SAVA	3.42	-	-	-1.93
2025-10-30	SAVA	3.28	-	-	-1.93
2025-10-31	SAVA	3.26	-	-	-1.93
2025-11-03	SAVA	3.20	-	-	-1.93
2025-11-04	SAVA	2.97	-	-	-1.93
2025-11-05	SAVA	3.04	-	-	-1.93
2025-11-06	SAVA	2.96	-	-	-1.93
2025-11-07	SAVA	2.96	-	-	-1.93
2025-11-10	SAVA	3.03	-	-	-1.93
2025-11-11	SAVA	3.11	-	-	-1.93
2025-11-12	SAVA	3.27	-	-	-1.93
2025-11-13	SAVA	2.92	-	-	-1.93
2025-11-14	SAVA	2.76	-	-	-1.93
2025-11-17	SAVA	2.78	-	-	-1.93
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	SAVA	4.09	-9.02	17.81
2025-10-21	SAVA	4.09	-9.02	17.81
2025-10-22	SAVA	4.09	-9.02	17.81
2025-10-23	SAVA	4.09	-9.02	17.81
2025-10-24	SAVA	4.09	-9.02	17.81
2025-10-27	SAVA	4.09	-9.64	16.40
2025-10-28	SAVA	4.09	-9.64	16.40
2025-10-29	SAVA	4.09	-9.64	16.40
2025-10-30	SAVA	4.09	-9.64	16.40
2025-10-31	SAVA	4.09	-9.64	16.40
2025-11-03	SAVA	4.09	-9.46	16.40
2025-11-04	SAVA	4.09	-9.46	16.40
2025-11-05	SAVA	4.09	-9.46	16.40
2025-11-06	SAVA	4.09	-9.46	16.40
2025-11-07	SAVA	4.09	-9.46	16.40
2025-11-10	SAVA	4.09	-9.20	16.40
2025-11-11	SAVA	4.09	-9.20	16.40
2025-11-12	SAVA	4.09	-9.20	17.70
2025-11-13	SAVA	4.09	-9.20	17.70
2025-11-14	SAVA	4.09	-9.20	17.69
2025-11-17	SAVA	4.10	-1.36	17.69
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.3

Avg. EPS Est. Next Quarter

-0.31

Insider Transactions

4.1

Institutional Transactions

-1.36

Beta

-1.04

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.1

Max Drawdown 5-Year %

-99.1

Target Price

P/E

Forward P/E

PEG

P/S

P/B

1.65

P/Free Cash Flow

EPS

-2.2

Average EPS Est. Cur. Y

-1.93

EPS Next Y. (Est.)

-1.22

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.34

Return on Equity vs Sector %

-156.9

Return on Equity vs Industry %

-142

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Cassava Sciences, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 30

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.

stock quote shares SAVA – Cassava Sciences, Inc. Stock Price stock today

news today SAVA – Cassava Sciences, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch SAVA – Cassava Sciences, Inc. yahoo finance google finance

stock history SAVA – Cassava Sciences, Inc. invest stock market

stock prices SAVA premarket after hours

ticker SAVA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: SAVA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y